T. D. de Villiers

South African Menopause Society Council consensus statement on menopausal hormone therapy.

T. D. de Villiers, 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion?

R. Baber, T. D. de Villiers, 2021, Climacteric : the journal of the International Menopause Society.

Bone health and osteoporosis in postmenopausal women.

T. D. de Villiers, 2009, Best practice & research. Clinical obstetrics & gynaecology.

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.

D. Kiel, M. Sabatine, J. Reginster, 2019, The lancet. Diabetes & endocrinology.

Romosozumab Improves Lumbar Spine Bone Mass and Bone Strength Parameters Relative to Alendronate in Postmenopausal Women: Results From the ARCH Trial.

Jacques P. Brown, T. Keaveny, K. Engelke, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.

R. Chapurlat, S. Bonnick, S. Palacios, 2013, The Journal of clinical endocrinology and metabolism.

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial

Jacques P. Brown, T. Keaveny, K. Engelke, 2021, Journal of Bone and Mineral Research.

Therapeutic Equivalence of Alendronate 35 Milligrams Once Weekly and 5 Milligrams Daily in the Prevention of Postmenopausal Osteoporosis

J. Orloff, A. Santora, M. Luckey, 2003, Obstetrics and gynecology.

Morphea-like skin lesions reported in the Phase III Long-term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis.

C. Kovarik, H. Jacobe, P. Alexandersen, 2020, Journal of American Academy of Dermatology.